You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Rehovot, Israel-based precision medicine firm will use the funding to scale clinical trials and expansion to the UK.
Most of the scroll fragments analyzed originated from sheep, but two pieces came from cow, suggesting they were imported to the area where they were found.
New data shows that the test could eventually be useful in helping younger women avoid chemotherapy in the neoadjuvant setting.
A new microbiome analysis uncovered cancer type-specific bacterial community features, along with intracellular bacteria in tumor and associated immune cells.
Tel Aviv University researchers have traced many coronavirus cases in Israel to a US strain, according to the Jerusalem Post.
The firm expects to launch a 510(k)-cleared version of its Bladder EpiCheck recurrence assay early next year followed by an RUO early-stage lung cancer assay.
News items for the week of May 11, 2020.
A Nature editorial calls for large, collaborative studies of potential COVID-19 treatments.
News items for the week of May 4, 2020.
News items for the week of April 27, 2020.
Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.
NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
In Science this week: review discusses advances in liquid biopsies, and more.